KKRC
PFE icon

Kohlberg Kravis Roberts & Co’s Pfizer PFE Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-149,668
Closed -$4.86M – 52
2017
Q1 		$4.86M Hold
149,668
– – 0.09% 38
2016
Q4 		$4.61M Hold
149,668
– – 0.07% 36
2016
Q3 		$4.81M Buy
+149,668
New +$5M 0.06% 39
2014
Q3 		– Sell
-190,247
Closed -$5.36M – 95
2014
Q2 		$5.36M Buy
190,247
+18,656
+11% +$532K 0.16% 32
2014
Q1 		$5.23M Buy
+171,591
New +$5.12M 0.09% 89

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's PFE Position: Q2 2017 in Review

Kohlberg Kravis Roberts & Co sold out of Pfizer (PFE) in Q2 2017, closing a stake of 149,668 shares — an estimated $4.86M sold.

Kohlberg Kravis Roberts & Co first reported a position in PFE in Q1 2014 and held it in 5 quarters. The position peaked at $5.36M in Q2 2014. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Kohlberg Kravis Roberts & Co reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 149,668 Pfizer shares in Q2 2017, an estimated $4.86M.
  • Kohlberg Kravis Roberts & Co first reported a position in Pfizer in Q1 2014 and held it in 5 quarters.
  • Kohlberg Kravis Roberts & Co's Pfizer position peaked at $5.36M in Q2 2014.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q2 2017, filed 14 Aug 2017.